Stay updated on Pembrolizumab in MM Residual Disease Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in MM Residual Disease Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    New study-record navigation items have been added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading has been standardized. A banner now shows No longer looking for participants, and the revision/version is updated to v3.6.0, replacing the previous v3.5.5.
    Difference
    0.4%
    Check dated 2026-06-11T23:29:58.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, indicating a newer release that likely includes small fixes or enhancements rather than substantive changes to study information.
    Difference
    0.1%
    Check dated 2026-06-05T00:08:53.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4, reflecting a new page version in the site's revision history. The core study details and content remain unchanged.
    Difference
    0.1%
    Check dated 2026-05-21T13:38:48.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page adds the disease term 'Multiple myeloma' and a related topics entry for MedlinePlus Genetics. The revision tag is updated from v3.5.2 to v3.5.3.
    Difference
    0.2%
    Check dated 2026-04-30T02:57:47.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Updated the page’s footer/version indicator to **Revision: v3.5.2** and removed some generic “related topics” link text.
    Difference
    0.2%
    Check dated 2026-04-22T18:02:29.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Added related topics: Multiple Myeloma and MedlinePlus Genetics to the study page.
    Difference
    0.2%
    Check dated 2026-04-15T16:11:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in MM Residual Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.